← European Medicine Shortage Tracker
26 medicines currently affected according to EMA shortages catalogue (EU) · updated 7 August 2026
28 product-level reports are open, 0 of them newly filed in August 2026. The longest-running open case is Verteporfin, reported on 2020-05-01 — about 75 months ago.
How to read this register: The EMA catalogue lists only shortages assessed at EU level — typically critical, multi-country cases for centrally authorised medicines. National registers list far more.
EU-level shortage work is steered by the MSSG — the Medicines Shortages Steering Group hosted at EMA — which assesses critical, multi-country shortages and coordinates member-state responses.
Member states now feed a common European Shortages Monitoring Platform (ESMP), and the EU maintains a Union list of critical medicines whose supply chains receive extra scrutiny; a Critical Medicines Act has been proposed to fund European manufacturing resilience.
An EMA catalogue entry signals coordination, not uniform scarcity: the same medicine can be exhausted in one member state and freely available in another, because distribution, pricing and stock decisions stay national.
For what you can actually collect at a pharmacy, the national register is authoritative — every medicine page on this tracker links each country's own record next to the EMA view.
The EMA catalogue covers shortages assessed at EU level — typically critical, multi-country cases. Your national register (linked from every medicine page) is the authoritative source for availability in your own country, and each EMA record carries patient and healthcare-professional guidance. Never stop a treatment on your own — confirm any switch with your pharmacist or prescriber.
Searched locally as: EMA shortage list, EU medicine shortage.
| Medicine | Status | Reported | Expected end |
|---|---|---|---|
| Aztreonam | Shortage | 2026-07-10 | — |
| Inotersen | Shortage | 2026-07-03 | — |
| Mycobutin (rifabutin) | Shortage | 2026-06-30 | — |
| Topiramate | Shortage | 2026-06-29 | — |
| Concentrate of proteolytic enzymes enriched in bromelain | Shortage | 2026-05-06 | — |
| Eli Lilly insulin (various forms) | Shortage | 2026-03-23 | — |
| Cyclophosphamide | Shortage | 2026-02-24 | — |
| Ifosfamide | Shortage | 2026-02-12 | — |
| Insulin lispro | Shortage | 2025-12-08 | — |
| Risperidone | Shortage | 2025-11-19 | — |
| Medicine | Status | Since | Expected end | Reports |
|---|---|---|---|---|
| Verteporfin | Shortage | 2020-05-01 | — | 1 |
| Parathyroid hormone | Shortage | 2022-05-02 | — | 1 |
| Insulin human | Shortage | 2023-01-24 | — | 1 |
| Liraglutide | Shortage | 2023-08-03 | — | 2 |
| Atomoxetine;methylphenidate;lisdexamfetamine | Shortage | 2023-12-18 | — | 1 |
| Vindesine | Shortage | 2024-02-23 | — | 1 |
| Fludarabine | Shortage | 2024-03-11 | — | 1 |
| Pancreas powder;pancrelipase | Shortage | 2024-04-29 | — | 1 |
| Human normal immunoglobulins | Shortage | 2024-06-03 | — | 1 |
| Olanzapine | Shortage | 2024-07-09 | — | 1 |
| Quetiapine | Shortage | 2025-03-11 | — | 1 |
| Parecoxib | Shortage | 2025-04-14 | — | 1 |
| Insulin aspart | Shortage | 2025-05-08 | — | 2 |
| Eptacog alfa (activated) | Shortage | 2025-05-12 | — | 1 |
| Human normal immunoglobulin | Shortage | 2025-11-11 | — | 1 |
| Mannitol | Shortage | 2025-11-14 | — | 1 |
| Risperidone | Shortage | 2025-11-19 | — | 1 |
| Insulin lispro | Shortage | 2025-12-08 | — | 1 |
| Ifosfamide | Shortage | 2026-02-12 | — | 1 |
| Cyclophosphamide | Shortage | 2026-02-24 | — | 1 |
| Eli Lilly insulin (various forms) | Shortage | 2026-03-23 | — | 1 |
| Concentrate of proteolytic enzymes enriched in bromelain | Shortage | 2026-05-06 | — | 1 |
| Topiramate | Shortage | 2026-06-29 | — | 1 |
| Mycobutin (rifabutin) | Shortage | 2026-06-30 | — | 1 |
| Inotersen | Shortage | 2026-07-03 | — | 1 |
| Aztreonam | Shortage | 2026-07-10 | — | 1 |
As of 7 August 2026, 26 medicines have open availability reports in EMA shortages catalogue (EU), covering 28 product-level entries. 0 new reports were filed in August 2026.
EMA shortages catalogue (EU) — this page aggregates it daily and links every entry back to the official record. The EMA catalogue lists only shortages assessed at EU level — typically critical, multi-country cases for centrally authorised medicines. National registers list far more.
Not necessarily. EMA lists shortages assessed at Union level — often critical, multi-country cases — but availability is national. Check your country's page on this tracker (linked below) for what your own register says, and expect the picture to differ between neighbouring countries.
Three concrete tracks: the MSSG coordinates responses to critical shortages, the ESMP gives regulators a shared live monitoring platform, and the Union critical-medicines list plus the proposed Critical Medicines Act aim public money at the root cause — Europe's dependence on a handful of overseas manufacturing sites for essential active ingredients.
Newsrooms and health sites may embed the live European Union (EMA) shortage count — free, with attribution:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/country/eu/embed.html" width="100%" height="130" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Medicine shortages in European Union (EMA)"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/country/eu/">Medicine shortages in European Union (EMA) — European Medicine Shortage Tracker</a> by MobiDoctor</p>